Genetic and Chemotherapeutic Influences on Germline Hypermutation

Overview

Journal Nature

Specialty Science

Date 2022 May 11

PMID 35545669

Authors

Joanna Kaplanis

Benjamin Ide

Rashesh Sanghvi

Matthew Neville

Petr Danecek

Tim Coorens

Elena Prigmore

Patrick Short

Giuseppe Gallone

Jeremy McRae

Jenny Carmichael

Angela Barnicoat

Helen Firth

Patrick OBrien

Raheleh Rahbari

Matthew Hurles

Affiliations

Soon will be listed here.

Abstract

Mutations in the germline generates all evolutionary genetic variation and is a cause of genetic disease. Parental age is the primary determinant of the number of new germline mutations in an individual's genome. Here we analysed the genome-wide sequences of 21,879 families with rare genetic diseases and identified 12 individuals with a hypermutated genome with between two and seven times more de novo single-nucleotide variants than expected. In most families (9 out of 12), the excess mutations came from the father. Two families had genetic drivers of germline hypermutation, with fathers carrying damaging genetic variation in DNA-repair genes. For five of the families, paternal exposure to chemotherapeutic agents before conception was probably a key driver of hypermutation. Our results suggest that the germline is well protected from mutagenic effects, hypermutation is rare, the number of excess mutations is relatively modest and most individuals with a hypermutated genome will not have a genetic disease.

Citing Articles

Direct measurement of the male germline mutation rate in individuals using sequential sperm samples.

Shoag J, Srinivasa A, Loh C, Liu M, Lassen E, Melanaphy S Nat Commun. 2025; 16(1):2546.

PMID: 40089484 DOI: 10.1038/s41467-025-57507-0.

Mutational signature analyses in multi-child families reveal sources of age-related increases in human germline mutations.

Shojaeisaadi H, Schoenrock A, Meier M, Williams A, Norris J, Palmer N Commun Biol. 2024; 7(1):1451.

PMID: 39506086 PMC: 11541588. DOI: 10.1038/s42003-024-07140-2.

Mechanisms of Germline Stem Cell Competition across Species.

Hodge R, Bach E Life (Basel). 2024; 14(10).

PMID: 39459551 PMC: 11509876. DOI: 10.3390/life14101251.

The importance of family-based sampling for biobanks.

Davies N, Hemani G, Neiderhiser J, Martin H, Mills M, Visscher P Nature. 2024; 634(8035):795-803.

PMID: 39443775 PMC: 11623399. DOI: 10.1038/s41586-024-07721-5.

Transgenerational transmission of post-zygotic mutations suggests symmetric contribution of first two blastomeres to human germline.

Jang Y, Tomasini L, Bae T, Szekely A, Vaccarino F, Abyzov A Nat Commun. 2024; 15(1):9117.

PMID: 39438473 PMC: 11496613. DOI: 10.1038/s41467-024-53485-x.

References

Kong A, Frigge M, Masson G, Besenbacher S, Sulem P, Magnusson G . Rate of de novo mutations and the importance of father's age to disease risk. Nature. 2012; 488(7412):471-5. PMC: 3548427. DOI: 10.1038/nature11396. View

Jonsson H, Sulem P, Kehr B, Kristmundsdottir S, Zink F, Hjartarson E . Parental influence on human germline de novo mutations in 1,548 trios from Iceland. Nature. 2017; 549(7673):519-522. DOI: 10.1038/nature24018. View

Conrad D, Keebler J, DePristo M, Lindsay S, Zhang Y, Casals F . Variation in genome-wide mutation rates within and between human families. Nat Genet. 2011; 43(7):712-4. PMC: 3322360. DOI: 10.1038/ng.862. View

Sasani T, Pedersen B, Gao Z, Baird L, Przeworski M, Jorde L . Large, three-generation human families reveal post-zygotic mosaicism and variability in germline mutation accumulation. Elife. 2019; 8. PMC: 6759356. DOI: 10.7554/eLife.46922. View

Lindsay S, Rahbari R, Kaplanis J, Keane T, Hurles M . Similarities and differences in patterns of germline mutation between mice and humans. Nat Commun. 2019; 10(1):4053. PMC: 6731245. DOI: 10.1038/s41467-019-12023-w. View

Amos W . Flanking heterozygosity influences the relative probability of different base substitutions in humans. R Soc Open Sci. 2019; 6(9):191018. PMC: 6774961. DOI: 10.1098/rsos.191018. View

Goldmann J, Wong W, Pinelli M, Farrah T, Bodian D, Stittrich A . Parent-of-origin-specific signatures of de novo mutations. Nat Genet. 2016; 48(8):935-9. DOI: 10.1038/ng.3597. View

Rahbari R, Wuster A, Lindsay S, Hardwick R, Alexandrov L, Al Turki S . Timing, rates and spectra of human germline mutation. Nat Genet. 2015; 48(2):126-133. PMC: 4731925. DOI: 10.1038/ng.3469. View

Gao Z, Moorjani P, Sasani T, Pedersen B, Quinlan A, Jorde L . Overlooked roles of DNA damage and maternal age in generating human germline mutations. Proc Natl Acad Sci U S A. 2019; 116(19):9491-9500. PMC: 6511033. DOI: 10.1073/pnas.1901259116. View

10.

Phillips D . Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair. DNA Repair (Amst). 2018; 71:6-11. PMC: 6219445. DOI: 10.1016/j.dnarep.2018.08.003. View

11.

Alexandrov L, Kim J, Haradhvala N, Huang M, Ng A, Wu Y . The repertoire of mutational signatures in human cancer. Nature. 2020; 578(7793):94-101. PMC: 7054213. DOI: 10.1038/s41586-020-1943-3. View

12.

Demanelis K, Jasmine F, Chen L, Chernoff M, Tong L, Delgado D . Determinants of telomere length across human tissues. Science. 2020; 369(6509). PMC: 8108546. DOI: 10.1126/science.aaz6876. View

13.

Alexandrov L, Jones P, Wedge D, Sale J, Campbell P, Nik-Zainal S . Clock-like mutational processes in human somatic cells. Nat Genet. 2015; 47(12):1402-7. PMC: 4783858. DOI: 10.1038/ng.3441. View

14.

Kucab J, Zou X, Morganella S, Joel M, Nanda A, Nagy E . A Compendium of Mutational Signatures of Environmental Agents. Cell. 2019; 177(4):821-836.e16. PMC: 6506336. DOI: 10.1016/j.cell.2019.03.001. View

15.

Forster L, Forster P, Lutz-Bonengel S, Willkomm H, Brinkmann B . Natural radioactivity and human mitochondrial DNA mutations. Proc Natl Acad Sci U S A. 2002; 99(21):13950-4. PMC: 129803. DOI: 10.1073/pnas.202400499. View

16.

Adewoye A, Lindsay S, Dubrova Y, Hurles M . The genome-wide effects of ionizing radiation on mutation induction in the mammalian germline. Nat Commun. 2015; 6:6684. PMC: 4389250. DOI: 10.1038/ncomms7684. View

17.

Huang K, Mashl R, Wu Y, Ritter D, Wang J, Oh C . Pathogenic Germline Variants in 10,389 Adult Cancers. Cell. 2018; 173(2):355-370.e14. PMC: 5949147. DOI: 10.1016/j.cell.2018.03.039. View

18.

Dutil J, Teer J, Golubeva V, Yoder S, Tong W, Arroyo N . Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico. Sci Rep. 2019; 9(1):17769. PMC: 6882826. DOI: 10.1038/s41598-019-54170-6. View

19.

Huang Q, Xu F, Shen H, Deng H, Liu Y, Liu Y . Mutation patterns at dinucleotide microsatellite loci in humans. Am J Hum Genet. 2002; 70(3):625-34. PMC: 384942. DOI: 10.1086/338997. View

20.

Gymrek M, Willems T, Reich D, Erlich Y . Interpreting short tandem repeat variations in humans using mutational constraint. Nat Genet. 2017; 49(10):1495-1501. PMC: 5679271. DOI: 10.1038/ng.3952. View